Cargando…
Immunotherapy in Pancreatic Adenocarcinoma: Beyond “Copy/Paste”
Immunotherapy has dramatically changed the cancer treatment landscape during the past decade, but very limited efficacy has been reported against pancreatic cancer. Several factors unique to pancreatic cancer may explain the resistance: the well-recognized suppressive elements in the tumor microenvi...
Autores principales: | Hester, Robert, Mazur, Pawel K., McAllister, Florencia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639640/ https://www.ncbi.nlm.nih.gov/pubmed/34193514 http://dx.doi.org/10.1158/1078-0432.CCR-18-0900 |
Ejemplares similares
-
Too much water drowned the miller: Akkermansia determines immunotherapy responses
por: Li, Le, et al.
Publicado: (2022) -
Therapeutic potential of microbial modulation in pancreatic cancer
por: Chandra, Vidhi, et al.
Publicado: (2021) -
The Human Microbiomes in Pancreatic Cancer: Towards Evidence-Based Manipulation Strategies?
por: Brandi, Giovanni, et al.
Publicado: (2021) -
Bacterial and fungal characterization of pancreatic adenocarcinoma from Endoscopic Ultrasound-guided biopsies
por: Wright, Robin D., et al.
Publicado: (2023) -
Targeting IL-17 for pancreatic cancer prevention
por: McAllister, Florencia, et al.
Publicado: (2014)